Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Field Study of TY014 in Yellow Fever (YF) Affected Areas of Brazil

Next Previous
Trial Profile

A Field Study of TY014 in Yellow Fever (YF) Affected Areas of Brazil

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 02 Dec 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs TY 014 (Primary)
  • Indications Yellow fever
  • Focus Therapeutic Use
  • Sponsors Tychan

Most Recent Events

  • 02 Dec 2019 New trial record
  • 18 Nov 2019 According to a Tychan media release, Tychan has received regulatory approval in Brazil to conduct a field study in YF affected areas.Dr Mauro Teixeira, Professor of Immunology at the Department of Biochemistry and Immunology, Universidade Federal de Minas Gerais, Brazil, is the principal investigator of this field study for TY014 in Brazil.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top